Source: Virtual Congress 2021 – Pleural disease and bronchoscopic lung volume reduction



Rating:

Share or cite this content

Citations should be made in the following way:
K. Kontogianni (Heidelberg, Germany), J. Brock (Heidelberg, Germany), F. Trudzinski (Heidelberg, Germany), C. Heussel (Heidelberg, Germany), F. Herth (Heidelberg, Germany), R. Eberhardt (Heidelberg, Germany). Evaluation of the Lung Volume Reduction Reverser System (LVR-R) in treating patients with severe emphysema. Feasibility and safety at 6 months follow up; preliminary results. 3799

Member's Comments

No comment yet.

Related content which might interest you: The REACH study, a randomized controlled trial assessing the safety and effectiveness of the Spiration Valve System endobronchial therapy for severe emphysema: 12 month follow-up results. Source: International Congress 2017 – Interventional pulmonology highlights 2017 Year: 2017 Long-term (5 year) safety of bronchial thermoplasty in patients with moderate to severe asthma: Asthma Intervention Research (AIR) Trial Source: Annual Congress 2010 - Aspects of severe asthma Year: 2010 Lung volume reduction coils (LVR-coils) for pulmonary emphysema: Results of the Italian National registry Source: Annual Congress 2013 –Bronchoscopic treatment of COPD and asthma: where are we going? Year: 2013 Outcome of surgical and endoscopic lung volume reduction with valves in patients with severe lung emphysema: current data of 246 patients with 3 months follow-up from a Lung Emphysema Registry in Germany Source: Virtual Congress 2020 – Challenging issues in thoracic surgery Year: 2020 Outcome of surgical and endoscopic lung volume reduction with valves in patients with severe lung emphysema: preliminary results from the national Lung Emphysema Registry (LE-R) in Germany Source: Virtual Congress 2021 – Innovation in thoracic surgery Year: 2021 Safety and Feasibility of Metered CryoSpray (MCS) for Patients with Chronic Bronchitis in COPD: 9 Month Results. Source: International Congress 2019 – Bronchoscopic treatment of COPD: hot news Year: 2019 Late Breaking Abstract - Bronchoscopic Thermal Vapor Ablation (BTVA) Outcomes at 12 months in Emphysema Patients with Severe Hyperinflation, a STEP-UP RCT Subgroup Analysis Source: International Congress 2017 – Late-breaking findings in asthma and COPD Year: 2017 Prospective assessment of incidental respiratory symptoms in COPD (PAIRS-COPD), feasibility study Source: International Congress 2014 – Diagnosis, imaging and surgery for thoracic tumours Year: 2014 A service evaluation of the accuracy of the Gold Standard Framework Proactive Indicator Guidance (GSF PIG)  in predicting 12 month mortality in patietns with a diagnosis of Chronic Obstructive Pulmonary Disease (COPD). Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD? Year: 2018 Late Breaking Abstract - Lung function tests in patients with previous SARS-COV2 pneumonia: a useful follow-up tool Source: Virtual Congress 2021 – Exacerbations of chronic respiratory diseases, including SARS-CoV-2 Year: 2021 Applying telemonitoring (TMon) post-admission for COPD, at scale: Preliminary findings from a large European trial Source: International Congress 2016 – Non-inflammatory COPD monitoring Year: 2016 Late Breaking Abstract - Early benefits in patient-reported outcomes (PROs) and physical activity (PA) in patients with severe eosinophilic asthma (SEA) treated with benralizumab: interim analysis of the imPROve Asthma study Source: Virtual Congress 2021 – Advances in asthma treatment Year: 2021 The value of pre trial rehabilitation before endoscopic lung volume reduction – Analysis of the VENT trial Source: International Congress 2014 – Latest insights in pulmonary rehabilitation Year: 2014 Pirfenidone post-authorization safety registry (PASSPORT) – Interim analysis of IPF treatment Source: International Congress 2014 – Clinical trials in IPF Year: 2014 LATE-BREAKING ABSTRACT: LAVOLTA I and II: Results of 2 phase III studies to assess the efficacy and safety of lebrikizumab in patients with uncontrolled asthma Source: International Congress 2016 – Late-breaking topics in airways disease Year: 2016 Long-term safety of pirfenidone in RECAP, an open-label extension study in patients with idiopathic pulmonary fibrosis, interim results Source: International Congress 2014 – Clinical trials in IPF Year: 2014 A single center experience with lung volume reduction coil (LVR-coil) treatment of patients with advanced emphysema. Effectiveness and complications after 1 year Source: International Congress 2016 – Endoscopic lung volume reduction II Year: 2016 Complications following bronchoscopic lung volume reduction (BLVR) – A small case series Source: Annual Congress 2013 –Bronchoscopic treatment of COPD and asthma: where are we going? Year: 2013 Understanding the analysis of the Canadian lung volume reduction surgery (CLVR) trial: future applications Source: Annual Congress 2008 - Congenital lung lesions and emphysema; lung cancer surgery Year: 2008 Study of the use of Chartis® pulmonary assessment system to optimize subject selection for endobronchial lung volume reduction (ELVR) – Results and subgroup analysis Source: Annual Congress 2011 - Endoscopic lung volume reduction: hype or hope? Year: 2011